Stock Movers Apogee Therapeutics Soars, Synopsys Gains, Norwegian Cruise Rises on Decline in Cost of Oil
Mar 23, 2026
A biotech stock jumps after mid-stage trial maintenance data showed deeper patient responses. A major activist investment reportedly lifts a chip-design software company's shares. Cruise lines rally as oil costs fall, boosting travel and transport names. Markets react to shifting geopolitical tensions that move energy-sensitive stocks.
AI Snips
Chapters
Transcript
Episode notes
Apogee Boosted By Strong Maintenance Trial Data
- Apogee Therapeutics stock jumped after mid-stage maintenance data showed deeper responses in moderate-to-severe atopic dermatitis patients.
- Citi analyst Jeff Meacham called the results a "home run" and the shares hit their highest intraday level since January 2020, lifting APGE about 18 percent.
Synopsys Rises After Elliott Stake Reports
- Synopsys shares rose roughly 5 percent after reports Elliott Investment Management made a multibillion-dollar stake in the chip-design software company.
- Bloomberg's reporting noted targets of Elliott often see positive stock moves both immediately and a year later, supporting SNPS gains.
Cruise Stocks Rally As Oil Costs Decline
- Norwegian Cruise Line shares led the S&P after oil prices fell, lifting travel and transportation names while energy stocks weakened.
- Carmen Reineke linked the move to lower oil costs and comments about postponed strikes, pushing NCLH up about 9 percent.